Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 0.038M
March 31, 2024 0.051M
December 31, 2023 0.067M
September 30, 2023 0.089M
June 30, 2023 0.052M
March 31, 2023 0.09M
December 31, 2022 0.175M
September 30, 2022 0.288M
June 30, 2022 0.386M
March 31, 2022 0.121M
December 31, 2021 0.232M
September 30, 2021 0.366M
June 30, 2021 0.452M
March 31, 2021 0.254M
December 31, 2020 0.353M
September 30, 2020 0.474M
June 30, 2020 0.459M
March 31, 2020 0.241M
December 31, 2019 0.261M
September 30, 2019 0.144M
June 30, 2019 0.23M
March 31, 2019 0.036M
December 31, 2018 0.087M
September 30, 2018 0.242M
June 30, 2018 0.13M
Date Value
March 31, 2018 0.065M
December 31, 2017 0.269M
September 30, 2017 0.452M
June 30, 2017 0.599M
March 31, 2017 2.743M
December 31, 2016 1.068M
September 30, 2016 1.729M
June 30, 2016 2.491M
March 31, 2016 3.925M
December 31, 2015 5.364M
September 30, 2015 6.656M
June 30, 2015 8.213M
March 31, 2015 9.556M
December 31, 2014 2.528M
September 30, 2014 1.212M
June 30, 2014 1.759M
March 31, 2014 1.696M
December 31, 2013 0.578M
September 30, 2013 0.64M
June 30, 2013 1.111M
March 31, 2013 0.731M
December 31, 2012 0.113M
September 30, 2012 0.508M
June 30, 2012 0.704M
March 31, 2012 0.758M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 117.98M
Exicure, Inc. 1.717M
Century Therapeutics, Inc. 119.71M
Absci Corp. 201.14M
Celularity, Inc. 6.175M